Skeletal stem cells and bone regeneration: Translational strategies from bench to clinic

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine

Volumn 224, Issue 12, 2010, Pages 1455-1470

  Tare, R S ^a   Kanczler, J ^a   Aarvold, A ^a   Jones, A M H ^a   Dunlop, D G ^a   Oreffo, R O C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

angiogenesis; osteogenesis; osteoprogenitor; skeletal stem cell; tissue regeneration; translational research

Indexed keywords

ANGIOGENESIS; OSTEOGENESIS; OSTEOPROGENITOR; TISSUE REGENERATION; TRANSLATIONAL RESEARCH; CLINICAL APPLICATION; DEGENERATIVE JOINT DISEASE; DEVELOPMENTAL BIOLOGY; ORTHOPAEDIC APPLICATIONS;

BONE; CYTOLOGY; DISEASE CONTROL; STEM CELLS; TISSUE; TISSUE ENGINEERING; BIOLOGY; CARTILAGE; CELL ENGINEERING; CELLS; MUSCULOSKELETAL SYSTEM; OSTEOBLASTS;

MUSCULOSKELETAL SYSTEM; TISSUE REGENERATION;

ANIMAL; BIOLOGICAL MODEL; BONE REGENERATION; CYTOLOGY; HUMAN; METHODOLOGY; OSTEOBLAST; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH;

ANIMALS; BONE REGENERATION; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSLATIONAL RESEARCH;

EID: 79952810439     PISSN: 09544119     EISSN: 20413033     Source Type: Journal    
DOI: 10.1243/09544119JEIM750     Document Type: Conference Paper

References (115)

1. Caplan A. Mesenchymal stem cells. J. Orthop. Res. 1991 ; 9: 641-650
2. Bianco P., Robey P. Handbook of stem cells. New York: Academic Press ; 2004: 415-424.
3. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P., Riminucci M., Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a haematopoietic microenvironment. Cell. 2007 ; 131: 324-336
4. Tare R., Babister J., Kanczler J., Oreffo R. Skeletal stem cells: Phenotype, biology and environmental niches informing tissue regeneration. Molec. Cell Endocrinology. 2008 ; 288: 11-21
5. Weiss L. The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rats. Anat. Rec. 1976 ; 186: 161-184
6. Barry F., Murphy J. Mesenchymal stem cells: Clinical applications and biological characterization. Int. J. Biochem. Cell Biology. 2004 ; 36: 568-584
7. Oreffo R., Cooper C., Mason C., Clements M. Mesenchymal stem cells: Lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005 ; 1: 169-178
8. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells. 2007 ; 25: 2739-2749
9. Simmons P., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991 ; 78: 55-62
10. Gronthos S., Graves S., Ohta S., Simmons P. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood. 1994 ; 84: 4164-4173
11. Howard D., Partridge K., Yang X., Clarke N., Okubo Y., Bessho K., Howdle S., Shakesheff K., Oreffo R. Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold. Biochem. Biophys. Res. Commun. 2002 ; 299: 208-215
12. Stewart K., Monk P., Walsh S., Jefferiss C., Letchford J., Beresford J. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: A comparative investigation in vitro. Cell Tissue Res. 2003 ; 313: 281-290
13. Letchford J., Cardwell A., Stewart K., Coogans K., Cox J., Lee M., Beresford J., Perry M., Welham M. Isolation of C15: A novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow. J. Immunol. Methods. 2006 ; 308: 124-137
14. Robledo M., Hidalgo A., Lastres P., Arroyo A., Bernabeu C., Sanchez-Madrid F., Teixido J. Characterization of TGF-beta-1-binding proteins in human bone marrow stromal cells. Br. J. Haematology. 1996 ; 93: 507-514
15. Joyner C., Bennett A., Triffitt J. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone. 1997 ; 21: 1-6
16. Zannettino A., Harrison K., Joyner C., Triffitt J., Simmons P. Molecular cloning of the cell surface antigen identified by the osteoprogenitor-specific monoclonal antibody, HOP-26. J. Cell Biochemistry. 2003 ; 89: 56-66
17. Bruder S., Ricalton N., Boynton R., Connolly T., Jaiswal N., Zaia J., Barry F. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J. Bone Miner. Res. 1998 ; 13: 655-663
18. Deschaseaux F., Charbord P. Human marrow stromal precursors are alpha 1 integrin subunit-positive. J. Cell Physiology. 2000 ; 184: 319-325
19. Gronthos S., Fitter S., Diamond P., Simmons P., Itescu S., Zannettino A. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. 2007 ; 16: 953-963
20. Majumdar M., Banks V., Peluso D., Morris E. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J. Cell Physiology. 2000 ; 185: 98-106
21. Pittenger M., Mackay A., Beck S., Jaiswal R., Douglas R., Mosca J., Moorman M., Simonetti D., Craig S., Marshak D. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 ; 284: 143-147
22. Owen M., Friedenstein A. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found. Symp. 1988 ; 136: 42-60
23. Park S., Oreffo R., Triffitt J. Interconversion potential of cloned human marrow adipocytes in vitro. Bone. 1999 ; 24: 549-554
24. Kuznetsov S., Mankani M., Gronthos S., Satomura K., Bianco P., Robey P. Circulating skeletal stem cells. J. Cell Biology. 2001 ; 153: 1133-1140
25. Mackay A., Beck S., Murphy J., Barry F., Chichester C., Pittenger M. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Engng. 1998 ; 4: 415-428
26. Johnstone B., Hering T., Caplan A., Goldberg V., Yoo J. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Expl Cell Res. 1998 ; 238: 265-272
27. Song L., Webb N., Song Y., Tuan R. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells. 2006 ; 24: 1707-1718
28. Liu T., Martina M., Hutmacher D., Hui J., Lee E., Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007 ; 25: 750-760
29. MacArthur B., Tare R., Murawski K., Oreffo R. Identification of candidate regulators of multipotency in human skeletal progenitor cells. Biochem. Biophys. Res. Commun. 2008 ; 377: 68-72
30. Nuttall M., Patton A., Olivera D., Nadeau D., Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J. Bone Miner. Res. 1998 ; 13: 371-382
31. Javazon E., Beggs K., Flake A. Mesenchymal stem cells: Paradoxes of passaging. Expl Hematology. 2004 ; 32: 414-425
32. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003 ; 101: 3722-3729
33. Ramasamy R., Fazekasova H., Lam E. W.-F., Soeiro I., Lombardi G., Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation. 2007 ; 83: 71-76
34. Tse W., Pendleton J., Beyer W., Egalka M., Guinan E. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation. 2003 ; 75: 389-397
35. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P., Matteucci P., Grisanti S., Gianni A. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002 ; 99: 3838-3843
36. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Expl Hematology. 2002 ; 30: 42-48
37. Jiang X., Zhang Y., Liu B., Zhang S., Wu Y., Yu X., Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005 ; 105: 4120-4126
38. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G., Pistoia V., Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006 ; 107: 367-372
39. Haniffa M., Collin M., Buckley C., Dazzi F. Mesenchymal stem cells: The fibroblasts' new clothes?. Haematologica. 2009 ; 94: 258-263
40. MacDermott R., Bragdon M. Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity. Behring. Inst. Mitt. 1983 ; 72: 122-128
41. Kneser U., Schaefer D. J., Polykandriotis E., Horch R. E. Tissue engineering of bone: The reconstructive surgeon's point of view. J. Cell Molec. Medicine. 2006 ; 10: 7-19
42. Gerber H. P., Vu T. H., Ryan A. M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Medicine. 1999 ; 5: 623-628
43. Carano R. A., Filvaroff E. H. Angiogenesis and bone repair. Drug Discov. Today. 2003 ; 8: 980-989
44. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S. R., Bouxsein M. L., Faugere M. C., Guldberg R. E., Gerstenfeld L. C., Haase V. H., Johnson R. S., Schipani E., Clemens T. L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 2007 ; 117: 1616-1626
45. Kanczler J. M., Oreffo R. O. Osteogenesis and angiogenesis: The potential for engineering bone. Eur. Cell Mater. 2008 ; 15: 100-114
46. Rivron N. C., Liu J. J., Rouwkema J., de Boer J., van Blitterswijk C. A. Engineering vascularised tissues in vitro. Eur. Cell Mater. 2008 ; 15: 27-40
47. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Gunther K. P., Dehio C., Puhl W., Brenner R. E. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 2002 ; 30: 472-477
48. Bouletreau P. J., Warren S. M., Spector J. A., Peled Z. M., Gerrets R. P., Greenwald J. A., Longaker M. T. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing. Plast. Reconstr. Surg. 2002 ; 109: 2384-2397
49. Ferrari G., Pintucci G., Seghezzi G., Hyman K., Galloway A. C., Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl Acad. Sci. USA. 2006 ; 103: 17260-17265
50. Deckers M. M., van Bezooijen R. L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S. E., Löwik C. W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002 ; 143: 1545-1553
51. Hausman M. R., Schaffler M. B., Majeska R. J. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone. 2001 ; 29: 560-564
52. Street J., Bao M., deGuzman L., Bunting S., Peale F. V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J. L., Daugherty A., van Bruggen N., Redmond H. P., Carano R. A., Filvaroff E. H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl Acad. Sci. USA. 2002 ; 99: 9656-9661
53. Sojo K., Sawaki Y., Hattori H., Mizutani H., Ueda M. Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs. J. Craniomaxillofac. Surg. 2005 ; 33: 238-245
54. Wan C., Gilbert S. R., Wang Y., Cao X., Shen X., Ramaswamy G., Jacobsen K. A., Alaql Z. S., Eberhardt A. W., Gerstenfeld L. C., Einhorn T. A., Deng L., Clemens T. L. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc. Natl Acad. Sci. USA. 2008 ; 105: 686-691
55. Guillotin B., Bareille R., Bourget C., Bordenave L., Amédée J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone. 2008 ; 42: 1080-1091
56. Villars F., Bordenave L., Bareille R., Amédée J. Effect of human endothelial cells on human bone marrow stromal cell phenotype: Role of VEGF?. J. Cell Biochemistry. 2000 ; 79: 672-685
57. Clarkin C. E., Garonna E., Pitsillides A. A., Wheeler-Jones C. P. Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: A negative modulatory role for prostanoids in VEGF-mediated cell: Cell communication?. Expl Cell Res. 2008 ; 314: 3152-3161
58. Grellier M., Ferreira-Tojais N., Bourget C., Bareille R., Guillemot F., Amédée J. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J. Cell Biochemistry. 2009 ; 106: 390-398
59. Grellier M., Granja P. L., Fricain J. C., Bidarra S. J., Renard M., Bareille R., Bourget C., Amédée J., Barbosa M. A. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials. 2009 ; 30: 3271-3278
60. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., Simank H. G., Richter W. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J. Bone Miner. Res. 2005 ; 20: 2028-2035
61. Kanczler J. M., Ginty P. J., Barry J. J., Clarke N. M., Howdle S. M., Shakesheff K. M., Oreffo R. O. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials. 2008 ; 29: 1892-1900
62. Patel Z. S., Young S., Tabat Y., Jansen J. A., Wong M. E., Mikos A. G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical sized defect model. Bone. 2008 ; 43: 931-940
63. Huang Y. C., Kaigler D., Rice K. G., Krebsbach P. H., Mooney D. J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 2005 ; 20: 848-857
64. Kempen D. H., Lu L., Heijink A., Hefferan T. E., Creemers L. B., Maran A., Yaszemski M. J., Dhert W. J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 2009 ; 30: 2816-2825
65. Reichert J. C., Saifzadeh S., Wullschleger M. E., Epari D. R., Schütz M. A., Duda G. N., Schell H., van Griensven M., Redl H., Hutmacher D. W. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials. 2009 ; 30: 2149-2163
66. Einhorn T. A. Clinically applied models of bone regeneration in tissue engineering research. Clin. Orthop. Related Res. 1999 ; 367: S59-67
67. Hollinger J. O., Kleinschmidt J. C. The critical size defect as an experimental model to test bone repair materials. J. Craniofac. Surg. 1990 ; 1: 60-68
68. Bolland B. J., Kanczler J. M., Dunlop D. G., Oreffo R. O. Development of in vivo muCT evaluation of neovascularisation in tissue engineered bone constructs. Bone. 2008 ; 43: 195-202
69. Bolland B. J., Kanczler J. M., Ginty P. J., Howdle S. M., Shakesheff K. M., Dunlop D. G., Oreffo R. O. The application of human bone marrow stromal cells and poly(dl-lactic acid) as a biological bone graft extender in impaction bone grafting. Biomaterials. 2008 ; 29: 3221-3227
70. Cowan C. M., Aghaloo T., Chou Y. F., Walder B., Zhang X., Soo C., Ting K., Wu B. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Engng. 2007 ; 13: 501-512
71. Kaigler D., Wang Z., Horger K., Mooney D. J., Krebsbach P. H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J. Bone Miner. Res. 2006 ; 21: 735-744
72. Montjovent M. O., Mark S., Mathieu L., Scaletta C., Scherberich A., Delabarde C., Zambelli P. Y., Bourban P. E., Applegate L. A., Pioletti D. P. Human fetal bone cells associated with ceramic reinforced PLA scaffolds for tissue engineering. Bone. 2008 ; 42: 554-564
73. Kanczler J. M., Mirmalek-Sani S. H., Hanley N. A., Ivanov A. L., Barry J. J., Upton C., Shakesheff K. M., Howdle S. M., Antonov E. N., Bagratashvili V. N., Popov V. K., Oreffo R. O. Biocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds. Acta Biomater. 2009 ; 5: 2063-2071
74. Yu H., Vandevord P. J., Gong W., Wu B., Song Z., Matthew H. W., Wooley P. H., Yang S. Y. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J. Orthop. Res. 2008 ; 26: 1147-1152
75. Oest M. E., Dupont K. M., Kong H. J., Mooney D. J., Guldberg R. E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J. Orthop. Res. 2007 ; 25: 941-950
76. Zhang X., Xie C., Lin A. S., Ito H., Awad H., Lieberman J. R., Rubery P. T., Schwarz E. M., O'Keefe R. J., Guldberg R. E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J. Bone Miner. Res. 2005 ; 20: 2124-2137
77. den Boer F. C., Patka P., Bakker F. C., Wippermann B. W., van Lingen A., Vink G. Q., Boshuizen K., Haarman H. J. New segmental long bone defect model in sheep: Quantitative analysis of healing with dual energy X-ray absorptiometry. J. Orthop. Res. 1999 ; 17: 654-660
78. Weiss S., Zimmermann G., Baumgart R., Kasten P., Bidlingmaier M., Henle P. Systemic regulation of angiogenesis and matrix degradation in bone regeneration-distraction osteogenesis compared to rigid fracture healing. Bone. 2005 ; 37: 781-790
79. Hannink G., Aspenberg P., Schreurs B. W., Buma P. Development of a large titanium bone chamber to study in vivo bone ingrowth. Biomaterials. 2006 ; 27: 1810-1816
80. Kondo N., Ogose A., Tokunaga K., Ito T., Arai K., Kudo N., Inoue H., Irie H., Endo N. Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle. Biomaterials. 2005 ; 26: 5600-5608
81. Suganuma J., Alexander H. Biological response of intramedullary bone to poly-l-lactic acid. J. Appl. Biomater. 1993 ; 4: 13-27
82. An Y. H., Woolf S. K., Friedman R. J. Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices. Biomaterials. 2000 ; 21: 2635-2652
83. National Joint Registry, 5th Annual Report, 2009.
84. Slooff T. J., Huiskes R., van Horn J., Lemmens A. J. Bone grafting in total hip replacement for acetabular protrusion. Acta Orthop. Scand. 1984 ; 55: 593-596
85. Schreurs B. W., Keurentjes J. C., Gardeniers J. W., Verdonschot N., Slooff T. J., Veth R. P. Acetabular revision with impacted morsellised cancellous bone grafting and a cemented acetabular component: A 20- to 25-year follow-up. J Bone Jt Surg Br. 2009 ; 91: 1148-1153
86. Halliday B. R., English H. W., Timperley A. J., Gie G. A., Ling R. S. Femoral impaction grafting with cement in revision total hip replacement. Evolution of the technique and results. J. Bone Jt Surg. Br. 2003 ; 85: 809-817
87. Eldridge J. D., Smith E. J., Hubble M. J., Whitehouse S. L., Learmonth I. D. Massive early subsidence following femoral impaction grafting. J. Arthroplasty. 1997 ; 12: 535-540
88. van Haaren E. H., Heyligers I. C., Alexander F. G., Wuisman P. I. High rate of failure of impaction grafting in large acetabular defects. J Bone Jt Surg. Br. 2007 ; 89: 296-300
89. Flecher X., Sporer S., Paprosky W. Management of severe bone loss in acetabular revision using a trabecular metal shell. J. Arthroplasty. 2008 ; 23: 949-955
90. Bobyn J. D., Poggie R. A., Krygier J. J., Lewallen D. G., Hanssen A. D., Lewis R. J., Unger A. S., O'Keefe T. J., Christie M. J., Nasser S., Wood J. E., Stulberg S. D., Tanzer M. Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Jt Surg. Am. 2004 ; 86: 123-129
91. Findlay D. M., Welldon K., Atkins G. J., Howie D. W., Zannettino A. C. W., Bobyn D. Osteoconductive scaffold, Adelaide 2004. The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials. 2004 ; 25: 2215-2227
92. Bullens P. H., Schreuder H. W., Malefijt M. C., Verdonschot N., Buma P. The presence of periosteum is essential for the healing of large diaphyseal segmental bone defects reconstructed with trabecular metal: A study in the femur of goats. J. Biomed. Mater. Res. B: Appl. Biomater. 2009
93. Taylor G. I., Miller G. D., Ham F. J. The free vascularized bone graft. A clinical extension of microvascular techniques. Plast. Reconstr. Surg. 1975 ; 55: 533-544
94. Eward W. C., Kontogeorgakos V., Levin L. S., Brigman B. E. Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection. Clin. Orthop. Related Res. 2009
95. Innocenti M., Abed Y. Y., Beltrami G., Delcroix L., Manfrini M., Capanna R. Biological reconstruction after resection of bone tumors of the proximal tibia using allograft shell and intramedullary free vascularized fibular graft: Long-term results. Microsurgery. 2009 ; 29: 361-372
96. Capanna R., Campanacci D. A., Belot N., Beltrami G., Manfrini M., Innocenti M., Ceruso M. A. New reconstructive technique for intercalary defects of long bones: The association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques. Orthop. Clin. North Am. 2007 ; 38: 51-60
97. Codivilla A. The classic: On the means of lengthening, in the lower limbs, the muscles and tissues which are shortened through deformity, 1905. Clin. Orthop. Related Res. 2008 ; 466: 2903-2909
98. Limb lengthening and reconstruction surgery. Rozbruch S. R. Ilizarov S., ed. New York: Informa Healthcare ; 2007
99. Vadalà G., Di Martino A., Tirindelli M. C., Denaro L., Denaro V. Use of autologous bone marrow cells concentrate enriched with platelet-rich fibrin on corticocancellous bone allograft for posterolateral multilevel cervical fusion. J. Tissue Engng Regen. Medicine. 2008 ; 2: 515-520
100. Kitoh H., Kitakoji T., Tsuchiya H., Katoh M., Ishiguro N. Distraction osteogenesis of the lower extremity in patients with achondroplasia/ hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma. J. Pediatr. Orthop. 2007 ; 27: 629-634
101. Alsousou J., Thompson M., Hulley P., Noble A., Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J. Bone Jt Surg. Br. 2009 ; 91: 987-996
102. Warnke P. H., Springer I. N., Wiltfang J., Acil Y., Eufinger H., Wehmöller M., Russo P. A., Bolte H., Sherry E., Behrens E., Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet. 2004 ; 364: 766-770
103. Warnke P. H., Wiltfang J., Springer I., Acil Y., Bolte H., Kosmahl M., Russo P. A., Sherry E., Lützen U., Wolfart S., Terheyden H. Man as living bioreactor: Fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials. 2006 ; 27: 3163-3167
104. Vacanti C. A., Bonassar L. J., Vacanti M. P., Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N. Engl. J. Medicine. 2001 ; 344: 1511-1514
105. Kon E., Muraglia A., Corsi A., Bianco P., Marcacci M., Martin I., Boyde A., Ruspantini I., Chistolini P., Rocca M., Giardino R., Cancedda R., Quarto R. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 2000 ; 49: 328-337
106. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S. M., Mukhachev V., Lavroukov A., Kon E., Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Medicine. 2001 ; 344: 385-386
107. Marcacci M., Kon E., Moukhachev V., Lavroukov A., Kutepov S., Quarto R., Mastrogiacomo M., Cancedda R. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Engng. 2007 ; 13: 947-955
108. Hernigou P., Poignard A., Zilber S., Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J. Orthop. 2009 ; 43: 40-45
109. Hernigou P., Poignard A., Beaujean F., Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J. Bone Jt Surg. Am. 2005 ; 87: 1430-1437
110. Bolland B. J., Partridge K., Tilley S., New A. M., Dunlop D. G., Oreffo R. O. Biological and mechanical enhancement of impacted allograft seeded with human bone marrow stromal cells: Potential clinical role in impaction bone grafting. Regen. Medicine. 2006 ; 1: 457-467
111. Tilley S., Bolland B. J., Partridge K., New A. M., Latham J. M., Dunlop D. G., Oreffo R. O. Taking tissue-engineering principles into theater: Augmentation of impacted allograft with human bone marrow stromal cells. Regen Medicine. 2006 ; 1: 685-692
112. Jones A. M. H., Foong T. S., New A. M., Bolland B. J. R. F., Pound J. C., Dunlop D. G., Oreffo R. O. The effect of skeletal stem cells, hydroxyapatite coated stem cells and collagen coated allograft on the biomechanical properties of impacted bone graft. Eur. Cell Mater. 2009 ; 18: 26
113. Cahill K. S., Chi J. H., Day A., Claus E. B. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. J. Am. Med. Ass. 2009 ; 302: 58-66
114. Mizuno M., Kuboki Y. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by Type I collagen. J. Biochemistry. 2001 ; 129: 133-138
115. Salasznyk R. M., Williams W. A., Boskey A., Batorsky A., Plopper G. E. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J. Biomed. Biotechnol. 2004 ; 1: 24-34